<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ben Kellman on Ben Kellman</title>
    <link>https://bkellman.github.io/</link>
    <description>Recent content in Ben Kellman on Ben Kellman</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2017 Ben Kellman</copyright>
    <lastBuildDate>Wed, 20 Apr 2016 00:00:00 +0000</lastBuildDate>
    <atom:link href="/" rel="self" type="application/rss+xml" />
    
    <item>
      <title>A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models</title>
      <link>https://bkellman.github.io/publication/tissue-specific-metabilic-modeling/</link>
      <pubDate>Fri, 07 Apr 2017 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/publication/tissue-specific-metabilic-modeling/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants</title>
      <link>https://bkellman.github.io/publication/nec-hmo/</link>
      <pubDate>Fri, 07 Apr 2017 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/publication/nec-hmo/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Example Talk</title>
      <link>https://bkellman.github.io/talk/example-talk/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/talk/example-talk/</guid>
      <description>&lt;p&gt;Embed your slides or video here using &lt;a href=&#34;https://gcushen.github.io/hugo-academic-demo/post/writing-markdown-latex/&#34; target=&#34;_blank&#34;&gt;shortcodes&lt;/a&gt;. Further details can easily be added using &lt;em&gt;Markdown&lt;/em&gt; and $\rm \LaTeX$ math code.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>AAAS: Give Science a Voice Ride</title>
      <link>https://bkellman.github.io/project/aaas-give-science-a-voice-ride/</link>
      <pubDate>Wed, 27 Apr 2016 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/project/aaas-give-science-a-voice-ride/</guid>
      <description>

&lt;p&gt;A fundraiser for AAAS&amp;rsquo; office of government relations. AAAS is an foundational organization responsible for publishing the magazine Science. Importantly, they are in DC advocating for the funding and use of rigorously obtained information; they advocate for &amp;ldquo;evidence-based reasoning.&amp;rdquo;&lt;/p&gt;

&lt;h2 id=&#34;social-media&#34;&gt;Social Media&lt;/h2&gt;

&lt;p&gt;Follow us on our &lt;a href=&#34;https://www.facebook.com/AAAS-Give-Science-a-Voice-Ride-1842317252690197/&#34; target=&#34;_blank&#34;&gt;facebook page&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;Follow us on twitter or instagram at &lt;a href=&#34;https://twitter.com/search?q=%23bike4science&amp;amp;src=typd&amp;amp;lang=en&#34; target=&#34;_blank&#34;&gt;#bike4science&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&#34;considering-joining-the-next-ride-let-us-know-today-https-docs-google-com-forms-d-e-1faipqlsd2ijm4z0uonbro34sjr1x-kms2e5rpozl8ddst0-an1ygf4g-viewform-usp-sf-link&#34;&gt;Considering joining the next ride? &lt;a href=&#34;https://docs.google.com/forms/d/e/1FAIpQLSd2IJm4Z0uoNBRo34sJr1X_kMs2e5Rpozl8DDST0-aN1yGF4g/viewform?usp=sf_link&#34; target=&#34;_blank&#34;&gt;Let us know today&lt;/a&gt;&lt;/h2&gt;

&lt;h2 id=&#34;why-raise-money-for-aaas&#34;&gt;Why raise money for AAAS&lt;/h2&gt;

&lt;p&gt;Today, advocates need money to be heard by our representatives. To that end, I would like to raise some money for these scientific advocates, AAAS.&lt;/p&gt;

&lt;p&gt;100% of donations will go directly to the AAAS Office of Government Relations. These are the folks responsible for interfacing with congress.&lt;/p&gt;

&lt;h2 id=&#34;more-on-aaas&#34;&gt;More on AAAS&lt;/h2&gt;

&lt;p&gt;Scientists need representation! Representation can pressure legislators to take climate change, research funding, knowledge, and academics seriously. AAAS is that organization.&lt;/p&gt;

&lt;p&gt;I just joined the AAAS. If you take the opinion and work of academics seriously, join the AAAS today. Get academics the representation we need to be heard, pressure our representatives to rely on facts and reason in their decision making.&lt;/p&gt;

&lt;p&gt;I would encourage everyone in and out of academia to join AAAS. Please encourage your friends and colleagues to do the same. #GiveKnowledgeAVoice&lt;/p&gt;

&lt;h2 id=&#34;join-aaas-today-https-www-aaas-org-membercentral-join-aaas&#34;&gt;&lt;a href=&#34;https://www.aaas.org/membercentral/join-aaas&#34; target=&#34;_blank&#34;&gt;Join AAAS Today&lt;/a&gt;&lt;/h2&gt;

&lt;p&gt;We cannot effect change alone! My bike ride is not important, AAAS is. The more members they have, the louder and more unified our voice becomes.&lt;/p&gt;

&lt;h2 id=&#34;unrelated-bike-stuff&#34;&gt;Unrelated Bike Stuff&lt;/h2&gt;

&lt;ul&gt;
&lt;li&gt;2016 - California State Champion - Men&amp;rsquo;s Category 3, age 25-29&lt;/li&gt;
&lt;li&gt;2017 - Kenda Cup Champion - Men&amp;rsquo;s Category 3, age 25-29&lt;/li&gt;
&lt;/ul&gt;
</description>
    </item>
    
    <item>
      <title>Human Milk Oligosaccharide (HMO) composition in relation to risk of Necrotizing Enterocolitis (NEC) – Nathan Lewis, Lars Bode</title>
      <link>https://bkellman.github.io/project/nec-hmo/</link>
      <pubDate>Wed, 27 Apr 2016 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/project/nec-hmo/</guid>
      <description>&lt;p&gt;A follow up on findings showing the mitigation of Necrotizing Enterocolitis (NEC) in a mouse model after administration of combined Human Milk Oligosaccharide (HMO) as well as a single HMO: DSLNT. We found that consecutive depletion of DSLNT in the mother’s milk was correlated with NEC onset in the infant. This finding is consistent with the pre-clinical rat model suggesting that DSLNT provides a significant protective effect for preterm infants from NEC.
The project will continue with the prediction of HMO biosynthesis pathways from gene expression data and the examination of microbiome contributions to NEC onset.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Transform Autism through Early Diagnosis - Nathan Lewis, Eric Couchesne</title>
      <link>https://bkellman.github.io/project/blood-based-autism-diagnosis/</link>
      <pubDate>Wed, 27 Apr 2016 00:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/project/blood-based-autism-diagnosis/</guid>
      <description>&lt;p&gt;In this project we are examining leukocyte RNAseq data collected from toddles evaluated at the Autism Center for Excellence.
Subjects have had a comprehensive range of behavior phenotyping over the first several years of life.
We hope to uncover the intrinsic dimensiality of the behavior-space defining Autism. We will create an informative diagnostic and prognostic tool for Autism by associating those composite behaviors with gene group regulation.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Examining the basis for between sample normalization</title>
      <link>https://bkellman.github.io/post/betweensamplenormalization/</link>
      <pubDate>Wed, 20 Apr 2016 12:00:00 +0000</pubDate>
      
      <guid>https://bkellman.github.io/post/betweensamplenormalization/</guid>
      <description>

&lt;h2 id=&#34;opinion-currently-under-review-as-of-8-7-2016&#34;&gt;&lt;em&gt;opinion currently under-review (as of 8/7/2016)&lt;/em&gt;&lt;/h2&gt;

&lt;p&gt;A friend pointed out to me recently that I should not be using FPKM for between sample comparisons and sent me &lt;a href=&#34;https://haroldpimentel.wordpress.com/2014/12/08/in-rna-seq-2-2-between-sample-normalization/&#34; target=&#34;_blank&#34;&gt;&lt;em&gt;this blog post&lt;/em&gt;&lt;/a&gt;. I had some thoughts about its validity and wanted to write them down.&lt;/p&gt;

&lt;p&gt;I believe the example used in this blogpost is not an reasonable. This prompted me to play a bit with the numbers and examine the robustness of FPKM in this respect.&lt;/p&gt;

&lt;p&gt;Clearly, FPKM (or library normalized counts) breaks down at 5 genes when 1 has a 20-fold increase in differential expression. That breakdown is indicated by the differential expression induced in all the other, stabely expressed, genes.
I&amp;rsquo;ve retooled the example above in general terms:
Normalized Count Treatment = Count_Gene_i / (Count_Gene_i x StableGenes + Count_Gene_Funky x FunkyGenes)&lt;/p&gt;

&lt;p&gt;$$NC_t = C_i / (C_i G_s + C_f G_f)$$
$$NC_t = 5/(5(5)+75(1)) = 0.05$$&lt;/p&gt;

&lt;p&gt;The concern is that this number diverges from the previous normalized count though it shouldn&amp;rsquo;t:
$$NC_c = 0.16 = 2/(2(5)+2(1))$$&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;As was pointed out in the blogplost, $NC_t \not= NC_c$ and that is incorrect.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;We can specify the expected Fold-Change for Stable genes as:
 $$E[FC] =  NC_t / NC_c $$
using &amp;ldquo;&amp;lsquo;&amp;rdquo; to denote the shift is observed expression, we can expand Fold change of a stable gene to:&lt;/p&gt;

&lt;p&gt;$$E[FC] = \frac{ C_i&amp;rsquo; / (C_i&amp;rsquo;  G_s + C_f&amp;rsquo;  G_f) }{ C_i / (C_i  G_s + C_f  G_f) }$$&lt;/p&gt;

&lt;p&gt;in the control condition $C_f = C_i$. So we can rewrite the above fold change as:&lt;/p&gt;

&lt;p&gt;$$ = \frac{ C_i&amp;rsquo; / (C_i&amp;rsquo; G_s + C_f&amp;rsquo; G_f) }{ C_i / (C_i G_s+G_f) } $$&lt;/p&gt;

&lt;p&gt;$$= \frac{ C_i&amp;rsquo; / (C_i&amp;rsquo; G_s + C_f&amp;rsquo; G_f) } { 1 / (G_s+G_f) } $$&lt;/p&gt;

&lt;p&gt;$$= \frac{ C_i&amp;rsquo; }{ (C_i&amp;rsquo; G_s + C_f&amp;rsquo; G_f) }  {  (G_s+G_f) }$$&lt;/p&gt;

&lt;p&gt;We can simplify by assuming that the funky genes will have an average of a 20-fold increase in expression. An average fold change of 20 is actually a good indication that there is something wrong with your design but I will get to that in a moment). Therefore $C_f&amp;rsquo; = 20C_i&amp;rsquo;$&lt;/p&gt;

&lt;p&gt;$$= \frac{ C_i&amp;rsquo; }{ (C_i&amp;rsquo; G_s + 20 C_i&amp;rsquo; G_f) }  {  (G_s+G_f) }$$&lt;/p&gt;

&lt;p&gt;$$= \frac{ 1 }{ ( G_s + 20 G_f) }  {  (G_s+G_f) }$$&lt;/p&gt;

&lt;p&gt;$$= \frac{  (G_s+G_f)}{( G_s + 20  G_f) } $$&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Actually, an expected or &amp;ldquo;average&amp;rdquo; value for fold change is 1.&lt;/strong&gt; There should be some upregulated, some down regulated, but on average, the expected fold-change of significantly differentially expressed genes is 1. That means that, on average, in a well-designed experiment: $E[C_f&amp;rsquo;] = 1C_i&amp;rsquo;$
$$E[FC]= \frac{  (G_s+G_f)}{( G_s + G_f) } = 1$$&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Once we correct the irregularly high fold change, the expected Fold-Change for Stable genes $E[FC]= 1$&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Let&amp;rsquo;s ignore the issue of the unrealistic fold-change for a moment&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;We should also consider that $G_f &amp;lt;&amp;lt;&amp;lt; G_s$. While $G_f$ is considered high if it comes close to 1,000 differentially expressed genes, $G_s$ in humans is typically between 20,000 and 150,000 depending on the annotation.
Therefore, we can say that there are 2-4 orders of magnitude seperating $G_f$ and $G_s$. Considering this, we can maintain the non-zero average fold change and approximate the above statement as:&lt;/p&gt;

&lt;p&gt;$$= \frac{  G_s+G_f}{ G_s + 20  G_f } $$
$$= \frac{  G_s+\epsilon}{ G_s + 20 \epsilon } $$
$$= \frac{  G_s}{ G_s  } $$&lt;/p&gt;

&lt;p&gt;Again, we find that with a realistic ratio of $G_f:G_s$, we expect a fold-change in stable genes close to 1 with a margin of error of 2-4 orders of magnitude.&lt;/p&gt;

&lt;p&gt;The problem with this example is it assumes a poorly designed or poorly controlled experiment where the average differential expression is 20-fold. If we, remove this mistake from the example, stable gene differential expression goes to 1 which is correct.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
